M&A Deal Summary

Luminex Acquires Merck KGaA - Flow Cytometry Portfolio

On October 18, 2018, Luminex acquired technology hardware company Merck KGaA - Flow Cytometry Portfolio from Merck for 63M EUR

Acquisition Highlights
  • This is Luminex’s 1st transaction in the Technology Hardware sector.
  • This is Luminex’s 0th largest (disclosed) transaction.
  • This is Luminex’s 1st transaction in Germany.

M&A Deal Summary
Date 2018-10-18
Target Merck KGaA - Flow Cytometry Portfolio
Sector Technology Hardware
Buyer(s) Luminex
Sellers(s) Merck
Deal Type Divestiture
Deal Value 63M EUR

Target

Merck KGaA - Flow Cytometry Portfolio

Darmstadt, Germany
Merck KGaA - Flow Cytometry Portfolio includes Amnis, the market-leading family of imaging flow cytometry products for cell-based analysis, as well as their Guava portfolio of products, which are economical, high-performance systems based on microcapillary technologies.

Search 200,500 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Buyer(S) 1

Buyer

Luminex

Austin, Texas, United States
Category Company
Founded 1995
Sector Medical Products
Employees1,325
Revenue 417M USD (2020)
DESCRIPTION

Luminex is a developer, manufacturer and marketer of proprietary instruments and assays utilizing xMAP open-architecture, multi-analyte platform and MultiCode real-time polymerase chain reaction (PCR) and multiplex PCR-based technologies, that deliver cost-effective and rapid results to clinicians and researchers. Luminex was founded in 1995 and is based in Austin, Texas.

DEAL STATS #
Overall 4 of 4
Sector (Technology Hardware) 1 of 1
Type (Divestiture) 1 of 1
Country (Germany) 1 of 1
Year (2018) 1 of 1
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2016-05-16 Nanosphere

Northbrook, Illinois, United States

Nanosphere, Inc. is a provider of molecular microbiology and molecular diagnostic market.

Buy $58M
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2023-02-13 Luminex Corp s Flow Cytometry & Imaging Business

Austin, Texas, United States

Luminex Corp's Flow Cytometry & Imaging (FCI) Business gives clients instant access to all facets of cellular phenotypes and morphology. Its microcapillary technology Innovative Guava provides miniaturized systems for quick cell counts, viability, and basic cell health analyses, or step up to the Guava easyCyte System, a versatile benchtop platform for additional, multi-dimensional cell health assessments.

Sell -

Seller(S) 1

SELLER

Merck

Darmstadt, Germany
Category Company
Founded 1668
Sector Diversified
Employees64,011
Revenue 21.0B EUR (2023)
DESCRIPTION

Merck is a science and technology company in healthcare, life science, and performance materials. Merck develops technologies that improve and enhance life from biopharmaceutical therapies to treat cancer or multiple sclerosis, cutting-edge systems for scientific research and production, to liquid crystals for smartphones and LCD televisions. Merck was founded in 1668 and is based in Darmstadt, Germany.

DEAL STATS #
Overall 7 of 7
Sector (Technology Hardware) 1 of 1
Type (Divestiture) 7 of 7
Country (Germany) 4 of 4
Year (2018) 2 of 2
Size (of disclosed) 5 of 7
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2018-04-19 Merck KGaA - Consumer Health Business

Darmstadt, Germany

Merck KGaA - Consumer Health Business is a portfolio of differentiated, physician-supported brands across a broad geographic footprint. Company is active across 44 countries and includes more than 900 products.

Sell €3.4B
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2019-01-28 Versum Materials

Allentown, Pennsylvania, United States

Versum Materials, Inc. is an electronic materials company providing high-purity chemicals and gases, delivery systems, services, and materials expertise to meet the evolving needs of the global semiconductor and display industries. Versum Materials Inc. is based in Allentown, Pennsylvania.

Buy €5.8B
Mergr

Product

Company

Legal